Lifelines Ltd.

Lifelines Ltd. specialises in portable EEG (electroencephalogram) amplifiers, such as the Trackit SOLO and Trackit T4 series, which are designed for recording and monitoring brainwave activity. They also produce photic stimulators, devices used alongside EEG systems to deliver controlled visual stimuli for diagnostic testing. These products cater to clinical and research applications in neurology.

Lifelines Ltd. is based in the United Kingdom (GB). Its devices are authorised for use in the European Union through compliance with EU Medical Device Regulations, and they are also listed in the FDA’s 510(k) premarket notification registry, indicating their intended use in the United States. This reflects the company’s focus on meeting regulatory requirements in both regions.

Lifelines Ltd.’s devices are listed in the EUDAMED database, which is the European Union’s transparency system for medical devices. Additionally, their products appear in the FDA’s 510(k) registry, demonstrating their compliance pathways for market authorisation in the United States. These listings help healthcare professionals and regulators verify device details and regulatory status.

Under the EU Medical Device Regulations, Lifelines Ltd.’s devices are classified as Class I, Class II, and Class IIa. The classification depends on factors like the device’s intended purpose, risk level, and interaction with the body. For example, standalone EEG amplifiers like the R-40 may fall into lower-risk categories (e.g., Class I or II), while more complex systems or those with higher risk may be classified as Class IIa, requiring stricter regulatory oversight.

The Trackit SOLO and Trackit T4 series are designed as portable EEG amplifiers, prioritising mobility and ease of use for clinical or research settings. The Trackit T4, in particular, appears to offer expanded functionality compared to the SOLO, likely accommodating more channels or advanced features for comprehensive brainwave monitoring. These devices are tailored for applications where portability and real-time recording are critical, such as ambulatory EEG studies or home-based diagnostics.